Fusion glycoprotein F0 — Drug Target

All drugs that target Fusion glycoprotein F0 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Marketed (2)

• Beyfortus · National Institute of Allergy and Infectious Diseases (NIAID) · Respiratory
• BEYFORTUS · ASTRAZENECA AB · Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] · Metabolic